Next 10 |
home / stock / bvaxf / bvaxf news
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order Canada NewsWire VANCOUVER, BC , May 16, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") announces that the Ontario Securities Commission (the...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Canada NewsWire USA News Group Commentary Issued on behalf of BioVaxys Technology Corp. VANCOUVER, BC , May 1, 2024 /CNW/ -- USA News Group ...
BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER Canada NewsWire VANCOUVER, BC , April 30, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") is pleased to announce that it has appointed Chris...
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY Canada NewsWire VANCOUVER, BC , and MADISON , Wis. , April 10, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: ...
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE PR Newswire VANCOUVER, B.C. , April 3, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:...
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT Canada NewsWire VANCOUVER, BC , March 22, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") announces that it intends to complete a non-brokered private placeme...
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update Canada NewsWire VANCOUVER, BC , March 7, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the man...
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order PR Newswire VANCOUVER, BC , March 6, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") today announced that the Ontario Securities Commissi...
BioVaxys Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications Canada NewsWire VANCOUVER, BC , March 5, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"...
Annual Financial Statements Update for the Year Ended October 31, 2023 Canada NewsWire VANCOUVER, BC , Feb. 21, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that as a result of delays in t...
News, Short Squeeze, Breakout and More Instantly...
Biondvax Pharms Ltd Ord Company Name:
BVAXF Stock Symbol:
OTCMKTS Market:
Biondvax Pharms Ltd Ord Website:
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order Canada NewsWire VANCOUVER, BC , May 16, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") announces that the Ontario Securities Commission (the...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Canada NewsWire USA News Group Commentary Issued on behalf of BioVaxys Technology Corp. VANCOUVER, BC , May 1, 2024 /CNW/ -- USA News Group ...
BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER Canada NewsWire VANCOUVER, BC , April 30, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") is pleased to announce that it has appointed Chris...